Compare FTHM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FTHM | MDCX |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Real Estate | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 26.2M |
| IPO Year | 2020 | N/A |
| Metric | FTHM | MDCX |
|---|---|---|
| Price | $0.88 | $0.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $23.50 |
| AVG Volume (30 Days) | 101.7K | ★ 544.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $335,184,000.00 | N/A |
| Revenue This Year | $30.07 | N/A |
| Revenue Next Year | $14.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.92 |
| 52 Week High | $3.37 | $8.90 |
| Indicator | FTHM | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 37.13 | 29.39 |
| Support Level | N/A | N/A |
| Resistance Level | $1.50 | $1.43 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 14.22 | 1.18 |
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.